Regeneron Acquires Bankrupt 23andMe's Assets for $256 Million Amidst Potential Layoffs in San Francisco
Regeneron Pharmaceuticals is acquiring the assets of 23andMe for $256 million, excluding its Lemonaid Health business, as the company faces layoffs and office closure due to financial struggles and a past cyberattack.
Latest News
20 minutes ago
About 1 hour ago
About 6 hours ago
Michigan Drivers Face 12-Cent Surge in Gas Prices Ahead of Memorial Day Travel
1 day ago
MudPenny to Open New Dining Venue at Hotel Rose in Downtown Rockford